Sponsored Early-onset colorectal cancer demands a new research playbook March 20, 2026Vol.52 No.11By Marwan Fakih
Conversation with The Cancer LetterFree Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.” March 13, 2026Vol.52 No.10By Paul Goldberg
Regulatory News Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again) March 13, 2026Vol.52 No.10By Claire Marie Porter
Regulatory News Prasad’s rule by fiat spilled into accelerated approvals in hematology and oncologyAtara Bio’s Cokey Nguyen: Normally, FDA wants to help us succeed. Now, “we’re getting new guidance at the last minute and it’s not helping.” March 13, 2026Vol.52 No.10By Jacquelyn Cobb
Guest Editorial As more people are surviving cancer, we must continue funding bold science March 13, 2026Vol.52 No.10By Karen E. Knudsen
Cancer History ProjectFree The murder of Alexei Navalny is part of Russia’s macabre fascination with poisonsA gallop through history of poisonings—from hemlock, to mustard gas, to Polonium-210, to dart frog poison March 13, 2026Vol.52 No.10By Robert Peter Gale
News Analysis GRAIL presses on with Galleri test despite missed primary endpoint in pivotal studyWhere GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis March 06, 2026Vol.52 No.09By Jacquelyn Cobb and Sara Willa Ernst
Conversation with The Cancer Letter GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”Mainstream epidemiologists beg to differ March 06, 2026Vol.52 No.09By Jacquelyn Cobb and Sara Willa Ernst
Conversation with The Cancer Letter NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs March 06, 2026Vol.52 No.09By Jacquelyn Cobb and Sara Willa Ernst
FreeObituary Erin Cummings, Cancer Nation advocate, dies of stomach cancer at 68 March 06, 2026Vol.52 No.09
